Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1212-1225
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1212
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1212
Table 3 Partial correlation analysis between cystatin C, retinol-binding protein-4, U-α2- macroglobulin, U-podocalyxin, U-α-L-fucosidase, and clinical indicators
Indicator | CysC | RBP-4 | U-α2-MG/UCr | U-PCX/UCr | U-AFU/UCr | |||||
r | P value | r | P value | r | P value | r | P value | r | P value | |
UACR | 0.730 | < 0.001 | 0.625 | < 0.001 | 0.805 | < 0.001 | 0.639 | < 0.001 | 0.780 | < 0.001 |
eGFR | -0.816 | < 0.001 | -0.702 | < 0.001 | -0.711 | < 0.001 | -0.604 | < 0.001 | -0.742 | < 0.001 |
CysC | 1.000 | - | 0.693 | < 0.001 | 0.710 | < 0.001 | 0.645 | < 0.001 | 0.692 | < 0.001 |
RBP-4 | 0.693 | < 0.001 | 1.000 | - | 0.530 | < 0.001 | 0.432 | < 0.001 | 0.588 | < 0.001 |
U-α2-MG/UCr | 0.710 | < 0.001 | 0.530 | < 0.001 | 1.000 | - | 0.820 | < 0.001 | 0.874 | < 0.001 |
U-PCX/UCr | 0.645 | < 0.001 | 0.432 | < 0.001 | 0.820 | < 0.001 | 1.000 | - | 0.746 | < 0.001 |
U-AFU/UCr | 0.692 | < 0.001 | 0.588 | < 0.001 | 0.874 | < 0.001 | 0.746 | < 0.001 | 1.000 | - |
Scr | 0.953 | < 0.001 | 0.680 | < 0.001 | 0.755 | < 0.001 | 0.645 | < 0.001 | 0.715 | < 0.001 |
Urea | 0.799 | < 0.001 | 0.651 | < 0.001 | 0.657 | < 0.001 | 0.568 | < 0.001 | 0.703 | < 0.001 |
UTP/24 h | 0.665 | < 0.001 | 0.506 | < 0.001 | 0.740 | < 0.001 | 0.523 | < 0.001 | 0.743 | < 0.001 |
NLR | 0.417 | < 0.001 | 0.167 | 0.018 | 0.311 | < 0.001 | 0.299 | < 0.001 | 0.313 | < 0.001 |
hs-CRP | 0.067 | 0.343 | 0.079 | 0.267 | 0.094 | 0.186 | 0.111 | 0.118 | 0.087 | 0.222 |
- Citation: Li JJ, Sa RL, Zhang Y, Yan ZL. Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C. World J Diabetes 2024; 15(6): 1212-1225
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1212.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1212